LEQEMBI shows high treatment persistence in real-world study
Go back to LEQEMBI shows high treatment persistence in real-world study| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 202.15 -0.8 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $202.95 | 52 Week High | $333.65 | |||
| Open | $203.34 | 52 Week Low | $223.02 | |||
| Day High | $203.85 | P/E | 25.88 | |||
| Day Low | $199.58 | EPS | $7.81 | |||
| Volume | 227,507 | |||||

